Hemoglobin variability in epoetin-treated hemodialysis patients
- 1 October 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (4), 1514-1521
- https://doi.org/10.1046/j.1523-1755.2003.00229.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patientsNephrology Dialysis Transplantation, 2001
- Target guideline 5: Target haemoglobin concentration for the treatment of the anaemia of chronic renal failureNephrology Dialysis Transplantation, 1999
- Normalizing hematocrit in dialysis patients improves brain functionAmerican Journal of Kidney Diseases, 1999
- Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patientsNephrology Dialysis Transplantation, 1999
- Role of cytokines in the response to erythropoietin in hemodialysis patientsKidney International, 1998
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patientsAmerican Journal of Kidney Diseases, 1997
- The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1996
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989